Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987383) titled 'Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity' on May 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Wake Forest University Health Sciences
Condition:
Obesity
Intervention:
Drug: Vibegron
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: July 2025
Target Sample Size: 40
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06...